| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Copyright
|
|
|
|
158 |
S1 |
p. ii
|
article
|
| 2 |
OC-0068 Accuracy of a source-tracking method based on in vivo dosimetry for HDR prostate brachytherapy
|
Jørgensen, E.
|
|
|
158 |
S1 |
p. S53-S54
|
article
|
| 3 |
OC-0066 A multi-sensor-based dosimetry platform for real time source tracking in HDR brachytherapy
|
Linares Rosales, H.M.
|
|
|
158 |
S1 |
p. S51
|
article
|
| 4 |
OC-0014 APBI versus very APBI in the elderly: a comparison analysis of oncological outcome and late toxicity
|
Hannoun-Levi, J.
|
|
|
158 |
S1 |
p. S7
|
article
|
| 5 |
OC-0042 Applying column generation to the intensity-modulated high-dose-rate brachytherapy inverse planning
|
Antaki, M.
|
|
|
158 |
S1 |
p. S29-S30
|
article
|
| 6 |
OC-0011 Automated multi-criteria treatment planning for adaptive HDR-BT for locally advanced cervical cancer
|
Oud, M.
|
|
|
158 |
S1 |
p. S5-S6
|
article
|
| 7 |
OC-0132 Brachytherapy TG-43 dosimetry characterization of the INTRABEAM source
|
Ayala Alvarez, D.S.
|
|
|
158 |
S1 |
p. S97-S99
|
article
|
| 8 |
OC-0116 Cervical cancer brachytherapy training by 3D printing tissue equivalent patient anatomy from DICOMs
|
McGee, J.
|
|
|
158 |
S1 |
p. S85-S86
|
article
|
| 9 |
OC-0110 Characterisation of an inorganic scintillation detector system for time resolved in vivo dosimetry
|
Johansen, J.
|
|
|
158 |
S1 |
p. S77-S79
|
article
|
| 10 |
OC-0059 Clinical characteristics and risk factors for local failure in cervix cancer patients after MR IGABT
|
Schmid, M.
|
|
|
158 |
S1 |
p. S45
|
article
|
| 11 |
OC-0044 Clinical evaluation of an interactive multi-criteria optimisation workflow for HDR brachytherapy
|
Bélanger, C.
|
|
|
158 |
S1 |
p. S31-S33
|
article
|
| 12 |
OC-0103 Comparative study of brachytherapy vs. radical cystectomy for cT1-2 muscle-invasive bladder cancer
|
Pieters, B.
|
|
|
158 |
S1 |
p. S70-S72
|
article
|
| 13 |
OC-0062 Comparision Of Two Hdr Intracavitary Brachytherapy Regimens In Treatment Of Cervical Cancer
|
Krishna, A.
|
|
|
158 |
S1 |
p. S46-S47
|
article
|
| 14 |
OC-0130 Comprehensive 192Ir HDR QA using a pixel segmented ionization chamber
|
Lekatou, A.
|
|
|
158 |
S1 |
p. S94-S96
|
article
|
| 15 |
OC-0048 Correlation between radiation-induced foci from 192Ir brachytherapy and tumor nuclei Size
|
Behmand, B.
|
|
|
158 |
S1 |
p. S37-S38
|
article
|
| 16 |
OC-0013 Declining brachytherapy utilization for cervical cancer patients - have we reversed the trend?
|
Schad, M.D.
|
|
|
158 |
S1 |
p. S6-S7
|
article
|
| 17 |
OC-0069 Demonstration of 3D source tracking HDR brachytherapy treatment verification in a phantom
|
Hanlon, M.
|
|
|
158 |
S1 |
p. S54-S55
|
article
|
| 18 |
OC-0115 Detector-based quality assurance of assembled brachytherapy eye plaques
|
Moehle, S.
|
|
|
158 |
S1 |
p. S83-S85
|
article
|
| 19 |
OC-0112 development of a dynamic-shielding intensity modulated endorectal brachytherapy applicator
|
Thibodeau-Antonacci, A.
|
|
|
158 |
S1 |
p. S80-S82
|
article
|
| 20 |
OC-0058 Does dose to the ureter predict for ureteral stenosis? - Analysis of 3D MRI-based brachytherapy
|
Rodríguez-López, J.
|
|
|
158 |
S1 |
p. S44
|
article
|
| 21 |
OC-0133 Dosimetric characterizations of a novel inorganic scintillating detector - HDR brachytherapy
|
B.C. Debnath, S.
|
|
|
158 |
S1 |
p. S99
|
article
|
| 22 |
OC-0041 Dosimetric comparison of SBRT and HDR brachytherapy in patients from randomized study.
|
Nonikov, S.
|
|
|
158 |
S1 |
p. S28-S29
|
article
|
| 23 |
OC-0015 Dosimetric evaluation of OAR in APBI patients treated with multicatheter interstitial brachytherapy
|
Macaes, M.
|
|
|
158 |
S1 |
p. S8
|
article
|
| 24 |
OC-0107 Dosimetric Impact of CT and TRUS vs MR based volumes for Brachytherapy of Cervical Cancers
|
Swamidas, J.
|
|
|
158 |
S1 |
p. S75-S76
|
article
|
| 25 |
OC-0021 End-to-end verification of 3D printed applicators for HDR skin brachytherapy
|
Dewit, B.
|
|
|
158 |
S1 |
p. S12-S14
|
article
|
| 26 |
OC-0067 Establishing a Fingerprinting Method for Fast Catheter Identification in HDR Brachytherapy
|
Tho, D.
|
|
|
158 |
S1 |
p. S51-S52
|
article
|
| 27 |
OC-0113 Evaluation of early clinical response of CT-guided HDR interstitial brachytherapy in HCC
|
Walter, F.
|
|
|
158 |
S1 |
p. S82-S83
|
article
|
| 28 |
OC-0045 Extracting anatomical information from Iridium-192 gamma images using artificial intelligence
|
van Wagenberg, T.
|
|
|
158 |
S1 |
p. S33-S34
|
article
|
| 29 |
OC-0043 Feasibility Study of Quantitative Silicone Oxygen Sensors in HDR Cervical Cancer Brachytherapy
|
Cormack, R.
|
|
|
158 |
S1 |
p. S30-S31
|
article
|
| 30 |
OC-0064 First clinical results of integrated EM tracking for pre-treatment verification in prostate BT
|
Kolkman-Deurloo, I.
|
|
|
158 |
S1 |
p. S48-S49
|
article
|
| 31 |
OC-0020 Freiburg Flap Surface Applicator Brachytherapy positional accuracy on MR-only PETRA images
|
Kaza, E.
|
|
|
158 |
S1 |
p. S11-S12
|
article
|
| 32 |
OC-0135 GEC-ESTRO / ACROP recommendations for Quality Assurance of Ultrasound in Brachytherapy
|
Siebert, F.
|
|
|
158 |
S1 |
p. S101-S102
|
article
|
| 33 |
OC-0102 HDR brachytherapy as a single-day monotherapy: Survival results of a phase II randomized trial
|
Jolicoeur, M.
|
|
|
158 |
S1 |
p. S70
|
article
|
| 34 |
OC-0018 HDR 192-Ir surface brachytherapy in the treatment of basal cell skin cancer in elderly patients
|
Stankiewicz, M.
|
|
|
158 |
S1 |
p. S10
|
article
|
| 35 |
OC-0104 high-dose rate brachytherapy in localized penile cancer: clinical outcome analysis
|
Martz, N.
|
|
|
158 |
S1 |
p. S72-S73
|
article
|
| 36 |
OC-0016 High dose rate brachytherapy versus electron boost for tumor bed after breast conserving therapy
|
Bryantseva, J.
|
|
|
158 |
S1 |
p. S9
|
article
|
| 37 |
OC-0108 Impact of patient positioning on interstitial multicatheter HDR brachytherapy of the breast
|
Abu-Hossin, N.
|
|
|
158 |
S1 |
p. S76
|
article
|
| 38 |
OC-0109 Implant-based CT estimation towards adaptive breast brachytherapy
|
Dürrbeck, C.
|
|
|
158 |
S1 |
p. S76-S77
|
article
|
| 39 |
OC-0023 IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study
|
Pareek, V.
|
|
|
158 |
S1 |
p. S15-S16
|
article
|
| 40 |
OC-0027 Intensity modulated HDR ocular brachytherapy using Yb-169 and Se-75
|
Dupere, J.
|
|
|
158 |
S1 |
p. S18-S19
|
article
|
| 41 |
OC-0111 Intraluminal brachytherapy with chemoradiation versus chemoradiation alone in carcinoma of esophagus
|
Krishna, A.
|
|
|
158 |
S1 |
p. S79-S80
|
article
|
| 42 |
OC-0017 Long term outcomes of Carcinoma Buccal Mucosa treated with High Dose Rate Interstitial Brachytherapy
|
Bajwa, H.K.
|
|
|
158 |
S1 |
p. S9
|
article
|
| 43 |
OC-0099 Long-term outcomes of patients treated with I-125 seed implant versus surgery for prostate cancer
|
Locke, G.
|
|
|
158 |
S1 |
p. S67-S68
|
article
|
| 44 |
OC-0105 MRI-guided robotic needle insertion for prostate brachytherapy: proof of principle study in patients
|
Moerland, M.
|
|
|
158 |
S1 |
p. S73-S74
|
article
|
| 45 |
OC-0022 MRI-guided Treatment Planning for Skin Brachytherapy with PETRA
|
Lee, C.Y.
|
|
|
158 |
S1 |
p. S14-S15
|
article
|
| 46 |
OC-0047 Multi-criteria optimization integrating catheter optimization for prostate HDR brachytherapy
|
Chatigny, P.
|
|
|
158 |
S1 |
p. S35-S37
|
article
|
| 47 |
OC-0038 Outcomes in focal vs. dose-painted salvage HDR brachytherapy for locally recurrent prostate cancer
|
Navarro, I.
|
|
|
158 |
S1 |
p. S24-S25
|
article
|
| 48 |
OC-0063 Peritoneal spacing reduce OAR dose in cervical cancer BT. Preliminary results of a pilot study
|
Federico, M.
|
|
|
158 |
S1 |
p. S47-S48
|
article
|
| 49 |
OC-0061 Phase III randomized trial of trans-abdominal ultrasound in intra-cavitary brachytherapy in Cervix
|
Barthwal, M.
|
|
|
158 |
S1 |
p. S45-S46
|
article
|
| 50 |
OC-0039 Predicting biochemical failure after MR-guided focal HDR brachytherapy for recurrent prostate cancer
|
Willigenburg, T.
|
|
|
158 |
S1 |
p. S25-S27
|
article
|
| 51 |
OC-0060 Prediction of treatment response in patients with cervical cancer using midtreatment PET/MRI
|
withdrawn, Abstract
|
|
|
158 |
S1 |
p. S45
|
article
|
| 52 |
OC-0012 Reading Between the Voxels: Radiomic Predictors of Progression-Free Survival in Cervical Cancer
|
Zeitlin, R.
|
|
|
158 |
S1 |
p. S6
|
article
|
| 53 |
OC-0065 Real-time electromagnetic guidance for GYN interstitial HDR brachytherapy: a proof-of-concept
|
Cantin, A.
|
|
|
158 |
S1 |
p. S49-S51
|
article
|
| 54 |
OC-0134 Replacing TG-43U1 by TG-186 in HDR liver brachytherapy has a dosimetric impact on treatment plans
|
Duque, A.S.
|
|
|
158 |
S1 |
p. S99-S101
|
article
|
| 55 |
OC-0114 Results from the First Spanish National Survey on Epiescleral Brachytherapy for Uveal Melanoma
|
Rodriguez Rodriguez, I.
|
|
|
158 |
S1 |
p. S83
|
article
|
| 56 |
OC-0046 Robust optimization to mitigate rotational uncertainty effects in intensity modulated brachytherapy
|
Morén, B.
|
|
|
158 |
S1 |
p. S34-S35
|
article
|
| 57 |
OC-0019 Superficial HDR brachytherapy for skin lesions involving the finger – The Christie experience
|
Rembielak, A.
|
|
|
158 |
S1 |
p. S10-S11
|
article
|
| 58 |
OC-0025 Tumor regression of cervical cancer during chemoradiation evaluated by the T-score in EMBRACE I
|
Lindegaard, J.C.
|
|
|
158 |
S1 |
p. S16-S18
|
article
|
| 59 |
OC-0040 Ultrafractionated radiotherapy(RT) in localised prostate cancer:HDR brachytherapy vs stereotactic RT
|
Tsang, Y.M.
|
|
|
158 |
S1 |
p. S27-S28
|
article
|
| 60 |
OC-0037 Updated results of focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
|
Peters, M.
|
|
|
158 |
S1 |
p. S22-S23
|
article
|
| 61 |
OC-0106 US-guided EM tracked system compared to OncentraProstate for HDR brachytherapy: a first in-men study
|
Lavallee, M.C.
|
|
|
158 |
S1 |
p. S74-S75
|
article
|
| 62 |
OC-0131 WP21 BRAPHYQS survey of differences in 192Ir and 60Co brachytherapy RAKR determinations
|
Vijande, J.
|
|
|
158 |
S1 |
p. S96-S97
|
article
|
| 63 |
OC-0101 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients
|
Vigneault, E.
|
|
|
158 |
S1 |
p. S69-S70
|
article
|
| 64 |
OC-0100 20 years of iodine-seed prostate brachytherapy: monotherapy-outcomes in 1013 patients
|
Goñi Ramirez, A.
|
|
|
158 |
S1 |
p. S68-S69
|
article
|
| 65 |
PO-0261 Adjuvant HDR contact brachytherapy for localized penile cancer: long-term toxicities and outcomes
|
Pircalab, P.
|
|
|
158 |
S1 |
p. S214
|
article
|
| 66 |
PO-0206 A dosimetric index to assess cervix brachytherapy implants: Dovix
|
Chimeno, J.
|
|
|
158 |
S1 |
p. S165-S166
|
article
|
| 67 |
PO-0263 A Matlab toolkit for Ru-106 eye plaque QA, dose calculation, reference table and report generation
|
Delombaerde, L.
|
|
|
158 |
S1 |
p. S215-S217
|
article
|
| 68 |
PO-0201 A Miniature Robotic System for Interstitial Brachytherapy Needle Insertion
|
Buzurovic, I.
|
|
|
158 |
S1 |
p. S160-S161
|
article
|
| 69 |
PO-0233 A multi-protocol validation study of automated bi-objective planning for HDR prostate brachytherapy
|
Bouter, A.
|
|
|
158 |
S1 |
p. S195-S197
|
article
|
| 70 |
PO-0186 Analysis of Outcomes and Cost Effectiveness of Inpatient vs.Outpatient Based Interstitial Vaginal Brachytherapy
|
Azghadi, S.
|
|
|
158 |
S1 |
p. S148
|
article
|
| 71 |
PO-0219 Analysis of the image quality of two different I-125 seed models using TRUS, MR and CT
|
Hermani, H.
|
|
|
158 |
S1 |
p. S181-S182
|
article
|
| 72 |
PO-0177 A new software for designing patient-specific sleeves for the Montreal split-ring applicator
|
Basaric, B.
|
|
|
158 |
S1 |
p. S140-S141
|
article
|
| 73 |
PO-0215 A novel in-vivo 3D dosimetry device in GYN HDR brachytherapy using Micro Silica Bead TLDs
|
Jaberi, R.
|
|
|
158 |
S1 |
p. S175-S177
|
article
|
| 74 |
PO-0198 Applicator-guided SBRT boost combined with intracavitary brachytherapy for advanced cervical cancer
|
Constantinescu, C.
|
|
|
158 |
S1 |
p. S156-S158
|
article
|
| 75 |
PO-0188 Are active dwells always necessary in the applicator ring in the brachytherapy of cervical cancer?
|
Vízkeleti, J.
|
|
|
158 |
S1 |
p. S148-S149
|
article
|
| 76 |
PO-0190 A single institution review of vaginal brachytherapy with customised moulds and interstitial needles
|
Flower, E.
|
|
|
158 |
S1 |
p. S150-S151
|
article
|
| 77 |
PO-0254 A systematic review of intraluminal HDR brachytherapy in the management of cholangiocarcinoma
|
Taggar, A.
|
|
|
158 |
S1 |
p. S210
|
article
|
| 78 |
PO-0225 Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy
|
Chimeno, J.
|
|
|
158 |
S1 |
p. S188
|
article
|
| 79 |
PO-0211 BrachyClip with I-125 seed
|
Dupere, J.
|
|
|
158 |
S1 |
p. S170-S171
|
article
|
| 80 |
PO-0262 Brachytherapy for paediatric pelvic tumours – sole local therapy modality and combined with surgery
|
Chard, J.
|
|
|
158 |
S1 |
p. S214-S215
|
article
|
| 81 |
PO-0174 Cervix cancer treated with PDR brachytherapy boost
|
Dickie, G.
|
|
|
158 |
S1 |
p. S138-S139
|
article
|
| 82 |
PO-0218 Characterising a Papillon 50 electronic brachytherapy source using a plastic scintillation detector
|
Georgi, P.
|
|
|
158 |
S1 |
p. S179-S181
|
article
|
| 83 |
PO-0195 Clinical outcome of intracavitary and interstitial brachytherapy in locally advanced cervical cancer
|
Chitmanee, P.
|
|
|
158 |
S1 |
p. S154
|
article
|
| 84 |
PO-0176 Clinical outcomes of cervical cancer with CT-based image-guided brachytherapy
|
Chan, W.L.
|
|
|
158 |
S1 |
p. S139-S140
|
article
|
| 85 |
PO-0251 clinical outcomes of radiation therapy for high-risk prostate cancer
|
Gumenetskaya, Y.
|
|
|
158 |
S1 |
p. S208
|
article
|
| 86 |
PO-0202 commissioning of a Venezia applicator: discrepancies between expected and actual source positions
|
Fuentemilla, N.
|
|
|
158 |
S1 |
p. S161-S162
|
article
|
| 87 |
PO-0200 Comparison of catheter position planning algorithms for HDR prostate brachytherapy under uncertainty
|
van der Meer, M.C.
|
|
|
158 |
S1 |
p. S159-S160
|
article
|
| 88 |
PO-0249 Comparison of two different Low Dose Rate (LDR) Brachytherapy techniques - a retrospective analysis
|
Villalon Arias, C.
|
|
|
158 |
S1 |
p. S206-S207
|
article
|
| 89 |
PO-0181 Comparison of vaginal doses and toxicities between two brachytherapy applicators in Carcinoma Cervix
|
Bajwa, H.K.
|
|
|
158 |
S1 |
p. S143
|
article
|
| 90 |
PO-0267 Contact Skin Radiotherapy for advanced non melanoma skin cancer during COVID-19 pandemic.
|
Lancellotta, V.
|
|
|
158 |
S1 |
p. S220-S221
|
article
|
| 91 |
PO-0246 Cost-effectiveness analysis of the use of blood patch as a pre-rectal spacer in brachytherapy.
|
Del Castillo, R.
|
|
|
158 |
S1 |
p. S205
|
article
|
| 92 |
PO-0255 CT-guided high-dose interstitial brachytherapy vs. SBRT in hepatocellular carcinoma
|
Walter, F.
|
|
|
158 |
S1 |
p. S210
|
article
|
| 93 |
PO-0205 Deep learning for automated applicator reconstruction in high-dose-rate prostate brachytherapy
|
Deufel, C.
|
|
|
158 |
S1 |
p. S164-S165
|
article
|
| 94 |
PO-0175 Deformable registration for HDR Cervical case: Dose accumulation for multiple deformation techniques
|
Narayana, V.
|
|
|
158 |
S1 |
p. S139
|
article
|
| 95 |
PO-0220 Determination of dose deposition from an Ocular Brachytherapy source: simulation data with TOPAS
|
Knoll, I.
|
|
|
158 |
S1 |
p. S182-S183
|
article
|
| 96 |
PO-0213 Development of equidistance marker to predict dwell position for MR-guided cervix brachytherapy
|
Kim, J.
|
|
|
158 |
S1 |
p. S172-S173
|
article
|
| 97 |
PO-0221 Doses to OAR during LDR permanent prostate treatment for monotherapy patient cohort
|
Keogh, T.
|
|
|
158 |
S1 |
p. S183-S185
|
article
|
| 98 |
PO-0196 Dosimetric Analysis of Combined Intracavitary and Interstitial Needles Placement for Cervical Cancer
|
Shiao, J.
|
|
|
158 |
S1 |
p. S154-S155
|
article
|
| 99 |
PO-0266 Dosimetric comparison of brachytherapy and tomotherapy for a large SCC on the scalp
|
Gonzalez Vaz, R.
|
|
|
158 |
S1 |
p. S219-S220
|
article
|
| 100 |
PO-0224 Dosimetric impact of a model based algorithm for skin cancer interventional radiotherapy
|
Placidi, E.
|
|
|
158 |
S1 |
p. S187-S188
|
article
|
| 101 |
PO-0208 Do the results improve when using inverse planning multi-solution tool in HDR prostate BT?
|
Fuentemilla, N.
|
|
|
158 |
S1 |
p. S167-S168
|
article
|
| 102 |
PO-0226 3-D Printed modified S-Tube for treatment of cervical cancer with high dose rate brachytherapy
|
Du Toit, M.
|
|
|
158 |
S1 |
p. S188-S189
|
article
|
| 103 |
PO-0241 EAU eligibility criteria for exclusive 125I brachytherapy for intermediate risk prostate cancer
|
Robin, S.
|
|
|
158 |
S1 |
p. S201-S202
|
article
|
| 104 |
PO-0217 Effect of transit dose on HDR brachytherapy – a 4D Monte Carlo study
|
withdrawn, Abstract
|
|
|
158 |
S1 |
p. S179
|
article
|
| 105 |
PO-0169 Effects of uncertainty with Strut Adjusted Volume Implant applicator in Japan.
|
Miyaura, K.
|
|
|
158 |
S1 |
p. S131
|
article
|
| 106 |
PO-0256 Episcleral Brachytherapy for Uveal Melanoma - Reference Center experience
|
Moura Fernandes, B.
|
|
|
158 |
S1 |
p. S211
|
article
|
| 107 |
PO-0182 Excellent Outcomes with CT-Based HDR Brachytherapy for Locally Advanced Cervical Cancer
|
Shiao, J.
|
|
|
158 |
S1 |
p. S143-S145
|
article
|
| 108 |
PO-0168 External beam radiotherapy and brachytherapy for partial breast irradiation: dosimetric comparison.
|
Irina, A.
|
|
|
158 |
S1 |
p. S131
|
article
|
| 109 |
PO-0178 Feasibility and Outcomes for Cervical Cancer Patients Treated with Hybrid Brachytherapy Applicators
|
Keller, A.
|
|
|
158 |
S1 |
p. S141-S142
|
article
|
| 110 |
PO-0234 Feasibility in using a nomogram as an independent verification process in HDR prostate brachytherapy
|
Monasor Denia, P.
|
|
|
158 |
S1 |
p. S197-S198
|
article
|
| 111 |
PO-0239 20 Gy HDR brachytherapy as monotherapy for localized prostate cancer: Early outcomes
|
González-Vidal, V.
|
|
|
158 |
S1 |
p. S201
|
article
|
| 112 |
PO-0199 HDR brachytherapy as a salvage therapy in head and neck cancers
|
Ait Erraisse, M.
|
|
|
158 |
S1 |
p. S158-S159
|
article
|
| 113 |
PO-0243 HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data
|
Novikov, S.
|
|
|
158 |
S1 |
p. S202-S203
|
article
|
| 114 |
PO-0244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up
|
Christianen, M.
|
|
|
158 |
S1 |
p. S203-S204
|
article
|
| 115 |
PO-0236 HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions
|
Biryukov, V.
|
|
|
158 |
S1 |
p. S199-S200
|
article
|
| 116 |
PO-0237 HDR monotherapy (2 fractions/1,5 Gy) in LR and favorable IR prostate cancer: analysis of toxicity.
|
Rodriguez Villalba, S.
|
|
|
158 |
S1 |
p. S200
|
article
|
| 117 |
PO-0245 HDR Monotherapy/LDR-EBRT/HDR-EBRT in patients with favorable IR prostate cancer: Long term results.
|
Rodriguez Villalba, S.
|
|
|
158 |
S1 |
p. S204-S205
|
article
|
| 118 |
PO-0235 HDR Prostate Brachytherapy – Is 20 needles too many?
|
Wilson, J.
|
|
|
158 |
S1 |
p. S199
|
article
|
| 119 |
PO-0216 Healthy tissue constraints for catheter position optimization in HDR prostate brachytherapy planning
|
van der Meer, M.C.
|
|
|
158 |
S1 |
p. S177-S179
|
article
|
| 120 |
PO-0258 How to design, fabricate, and validate a customized COMs-style eye plaque
|
Deufel, C.
|
|
|
158 |
S1 |
p. S212-S213
|
article
|
| 121 |
PO-0179 Hypnosedation for endocavitary uterovaginal applications: a pilot study
|
Kissel, M.
|
|
|
158 |
S1 |
p. S142
|
article
|
| 122 |
PO-0180 Impact of hybrid brachytherapy in cervical cancer: A survival and toxicity profile assessment
|
Pareek, V.
|
|
|
158 |
S1 |
p. S142-S143
|
article
|
| 123 |
PO-0170 Impact of risk factors for long-term breast recurrence of APBI with interstitial HDR brachytherapy
|
Guinot, J.
|
|
|
158 |
S1 |
p. S132
|
article
|
| 124 |
PO-0193 Impact of Vaginal Reference Length on Organs at Risk doses in Carcinoma Cervix Brachytherapy
|
Bajwa, H.K.
|
|
|
158 |
S1 |
p. S153
|
article
|
| 125 |
PO-0260 INTERBOARD: a dedicated tumor board to deal with personalized medicine in interventional oncology.
|
Casà, C.
|
|
|
158 |
S1 |
p. S213-S214
|
article
|
| 126 |
PO-0194 Intracavitary brachytherapy for endometrial carcinoma: experience with Co-60 HDR brachytherapy.
|
Domínguez Rullán, J.A.
|
|
|
158 |
S1 |
p. S153
|
article
|
| 127 |
PO-0183 Intracavitary electronic brachytherapy (e-BT) for gynecological malignancies
|
Sarria, G.R.
|
|
|
158 |
S1 |
p. S145
|
article
|
| 128 |
PO-0265 Intraluminal HDR brachytherapy as a component of induction chemoradiotherapy for esophageal cancer
|
Tuiriaeva, E.
|
|
|
158 |
S1 |
p. S218-S219
|
article
|
| 129 |
PO-0171 Intraoperative Brachytherapy (HDR-IOBT) in advanced or recurrence gynecologic cancer.
|
Visus, I.
|
|
|
158 |
S1 |
p. S132-S133
|
article
|
| 130 |
PO-0228 Inverse versus forward optimisation methods in brachytherapy of breast, cervix and prostate cancer
|
Fröhlich, G.
|
|
|
158 |
S1 |
p. S189-S190
|
article
|
| 131 |
PO-0214 Investigation of obstructions in ring applicators during pulsed dose rate cervix brachytherapy
|
Menon, G.
|
|
|
158 |
S1 |
p. S173-S175
|
article
|
| 132 |
PO-0223 Ir-192 position measurement for pre-treatment QA using a fluorescent screen-based optical detector
|
Lee, W.Y.
|
|
|
158 |
S1 |
p. S185-S186
|
article
|
| 133 |
PO-0185 Kelowna GYN template-based high-dose rate interstitial brachytherapy: design and dosimetric results
|
Shiao, J.
|
|
|
158 |
S1 |
p. S146-S147
|
article
|
| 134 |
PO-0238 LDR-HDR boost in patients with intermediate-risk prostate cancer. A single Institution experience.
|
Rodriguez Villalba, S.
|
|
|
158 |
S1 |
p. S200-S201
|
article
|
| 135 |
PO-0250 MRI-Guided Robotic Prostate Biopsy and Brachytherapy: Update from the EU-funded CoBra Project
|
Wilby, S.
|
|
|
158 |
S1 |
p. S207-S208
|
article
|
| 136 |
PO-0173 Needle localization in MRI-guided gynecological brachytherapy using a PETRA sequence
|
Kaza, E.
|
|
|
158 |
S1 |
p. S136-S138
|
article
|
| 137 |
PO-0264 orbital mold brachytherapy for recurrent orbital mesenchymal sarcoma: a contemporary approach
|
Yap, E.
|
|
|
158 |
S1 |
p. S217-S218
|
article
|
| 138 |
PO-0257 Perioperative Radiation with/without High Dose Rate Brachytherapy for High-risk Soft Tissue Sarcoma
|
Assif, J.
|
|
|
158 |
S1 |
p. S211
|
article
|
| 139 |
PO-0232 Permanent seed prostate brachytherapy : long term results of a large single center
|
Taussky, D.
|
|
|
158 |
S1 |
p. S195
|
article
|
| 140 |
PO-0191 Plan evaluation of the interstitial contribution in brachytherapy for cancer cervix
|
Joy, A.
|
|
|
158 |
S1 |
p. S151
|
article
|
| 141 |
PO-0209 Practical considerations on the use of EM tracking technology for clinical HDR brachytherapy
|
Lavallee, M.C.
|
|
|
158 |
S1 |
p. S168-S169
|
article
|
| 142 |
PO-0222 Primary standards and measurement methods for X-ray emitting electronic brachytherapy devices
|
Schneider, T.
|
|
|
158 |
S1 |
p. S185
|
article
|
| 143 |
PO-0247 Prostate HDR boost: urethra V110 constraints correspond to low adverse effects
|
Iftimia, I.
|
|
|
158 |
S1 |
p. S206
|
article
|
| 144 |
PO-0240 Prostate radiotherapy rectal sparing: synergy with combo-brachy, gradient optimization, and SpaceOAR
|
withdrawn, Abstract
|
|
|
158 |
S1 |
p. S201
|
article
|
| 145 |
PO-0192 Prototype testing the 3D-printed Montreal split-ring applicator (GYN) using biocompatible materials
|
Kamio, Y.
|
|
|
158 |
S1 |
p. S152-S153
|
article
|
| 146 |
PO-0207 Radiation protection preparedness using LASAIR in case of malevolent use of brachytherapy sources
|
Palmqvist, T.
|
|
|
158 |
S1 |
p. S166-S167
|
article
|
| 147 |
PO-0203 Range of intra-fraction dose uncertainty in cervical cancer HDR brachytherapy.
|
Ferrándiz, V.
|
|
|
158 |
S1 |
p. S162-S163
|
article
|
| 148 |
PO-0253 Real-time intraoperative-planning reduces toxicity in LDR-brachytherapy-boost in prostate cancer
|
Barrado, M.
|
|
|
158 |
S1 |
p. S209
|
article
|
| 149 |
PO-0259 Single-fraction adjuvant electronic brachytherapy after resection of conjunctival carcinoma
|
Sarria, G.R.
|
|
|
158 |
S1 |
p. S213
|
article
|
| 150 |
PO-0210 Status of HDR measurements at PTB
|
Behrens, R.
|
|
|
158 |
S1 |
p. S169-S170
|
article
|
| 151 |
PO-0230 Subdomains of erectile and urinary function after ultrafocal HDR-brachytherapy for prostate cancer
|
Peters, M.
|
|
|
158 |
S1 |
p. S192-S193
|
article
|
| 152 |
PO-0197 Systemic analysis of vaginal wall dose between various vaginal brachytherapy: phantom case
|
Kim, R.
|
|
|
158 |
S1 |
p. S155-S156
|
article
|
| 153 |
PO-0252 Technical Evaluation of 3D printed Disposable Seed Loader for LDR Cs-131 Prostate Brachytherapy
|
Khosravi, M.
|
|
|
158 |
S1 |
p. S208-S209
|
article
|
| 154 |
PO-0248 The one-hundred most-cited publications in prostate brachytherapy
|
Taussky, D.
|
|
|
158 |
S1 |
p. S206
|
article
|
| 155 |
PO-0189 The second planning-CT in a two daily fractions implant can be omitted in cervical cancer IGABT
|
Engel, O.
|
|
|
158 |
S1 |
p. S149-S150
|
article
|
| 156 |
PO-0204 Towards an absolute dosimetry for 192-Ir high dose rate sources with micro-ionization chamber
|
Martínez Albaladejo, M.
|
|
|
158 |
S1 |
p. S163-S164
|
article
|
| 157 |
PO-0229 Towards informed and digitized HDR brachytherapy QA: Quantitative analysis of GYN applicators
|
Aldelaijan, S.
|
|
|
158 |
S1 |
p. S190-S192
|
article
|
| 158 |
PO-0172 Towards real-world quality cervical brachytherapy: how convergence met complexity, taxing capacity
|
Huang, F.
|
|
|
158 |
S1 |
p. S134-S136
|
article
|
| 159 |
PO-0242 Treatment outcomes and toxicity in patients treated with LDR brachytherapy, single institution study
|
Lukačko, P.
|
|
|
158 |
S1 |
p. S202
|
article
|
| 160 |
PO-0212 Use of rectal spacing hydrogel significantly reduces rectal dose in prostate LDR brachytherapy
|
Mehta, S.
|
|
|
158 |
S1 |
p. S171-S172
|
article
|
| 161 |
PO-0231 Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients
|
McMullan, T.
|
|
|
158 |
S1 |
p. S193-S194
|
article
|
| 162 |
PO-0187 Vaginal dose reduction by changing the ovoidloading pattern in intracavitary brachytherapy of cervix
|
Rangarajan, R.
|
|
|
158 |
S1 |
p. S148
|
article
|
| 163 |
PO-0227 Verification measurements for brachytherapy reference data
|
Wilks, R.
|
|
|
158 |
S1 |
p. S189
|
article
|
| 164 |
PO-0184 What do women say about their experiences of brachytherapy for cervical cancer? A qualitative study.
|
Humphrey, P.
|
|
|
158 |
S1 |
p. S146
|
article
|
| 165 |
PP-0148 A brachytherapy process review and failure mode effect analysis during a system replacement.
|
Flower, E.
|
|
|
158 |
S1 |
p. S112-S113
|
article
|
| 166 |
PP-0155 Antibiotic Prophylaxis for Prostate HDR Brachytherapy: Interim Results of a Phase III trial
|
Derashodian, T.
|
|
|
158 |
S1 |
p. S119-S120
|
article
|
| 167 |
PP-0120 Applicator visualization using ultrashort echo time MRI for HDR endorectal brachytherapy
|
Kerkhof, E.
|
|
|
158 |
S1 |
p. S89-S90
|
article
|
| 168 |
PP-0141 Assessment of interstitial needles with 3D-TRUS in cervical cancer brachytherapy
|
Knoth, J.
|
|
|
158 |
S1 |
p. S106
|
article
|
| 169 |
PP-0151 A treatment analysis tool for clinical dosimetric and outcome data reported in the EMBRACE trial
|
Ecker, S.
|
|
|
158 |
S1 |
p. S115-S116
|
article
|
| 170 |
PP-0145 Catheter displacements and dosimetric impact in focal salvage high-dose-rate prostate brachytherapy.
|
Moerland, M.
|
|
|
158 |
S1 |
p. S109-S110
|
article
|
| 171 |
PP-0150 Commissioning of a GPU-based multi-criteria optimisation algorithm for HDR brachytherapy
|
Bélanger, C.
|
|
|
158 |
S1 |
p. S113-S115
|
article
|
| 172 |
PP-0165 Contact X-Ray Brachytherapy for eyelid carcinoma: Efficacy and toxicity in 69 patients
|
Sumodhee, S.
|
|
|
158 |
S1 |
p. S128
|
article
|
| 173 |
PP-0118 Dosimeter evaluation for measurement of radial dose distributions for electronic brachytherapy
|
Walter, A.
|
|
|
158 |
S1 |
p. S87
|
article
|
| 174 |
PP-0149 Dosimetry of Intraocular Tumors with Small Apical Heights Using I-125 Plaques
|
Rezaee, M.
|
|
|
158 |
S1 |
p. S113
|
article
|
| 175 |
PP-0166 Failure modes and effects analysis guided implementation of 3D printed bolus for skin brachytherapy
|
Byrnes, K.
|
|
|
158 |
S1 |
p. S128-S129
|
article
|
| 176 |
PP-0164 focal treatment of prostate cancer with 169Yb-based high dose rate intensity modulated brachytherapy
|
Lavoie, J.
|
|
|
158 |
S1 |
p. S126-S128
|
article
|
| 177 |
PP-0119 8-Gy single-fraction HDR brachytherapy boost after WBI on localized breast cancer in young women
|
La Rosa de los Ríos, A.
|
|
|
158 |
S1 |
p. S87-S89
|
article
|
| 178 |
PP-0156 HDR and LDR comparison as monotherapy in localized prostate cancer: PSA kinetic and late toxicity
|
Reynaud, T.
|
|
|
158 |
S1 |
p. S120
|
article
|
| 179 |
PP-0121 HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial
|
Jolicoeur, M.
|
|
|
158 |
S1 |
p. S90-S91
|
article
|
| 180 |
PP-0159 HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
|
Moreno Olmedo, E.
|
|
|
158 |
S1 |
p. S123
|
article
|
| 181 |
PP-0117 HDR BT in Non melanoma Skin Cancer: Results and toxicity with different techniques and applicators.
|
Rodriguez Villalba, S.
|
|
|
158 |
S1 |
p. S86
|
article
|
| 182 |
PP-0143 Hybrid Tandem & Ovoids Brachytherapy in Locally Advanced Cervical Cancer: Dose & Tumor Volume Metrics
|
Rivera, A.
|
|
|
158 |
S1 |
p. S107
|
article
|
| 183 |
PP-0144 Intensity modulated HDR GYN cervix brachytherapy
|
Dupere, J.
|
|
|
158 |
S1 |
p. S108-S109
|
article
|
| 184 |
PP-0153 In Vivo Dosimetry in brachytherapy: A first clinical trial implementation with a mPSD detector
|
withdrawn, Abstract
|
|
|
158 |
S1 |
p. S118
|
article
|
| 185 |
PP-0154 Knowledge-based Inverse Treatment Planning for Low-Dose-Rate Prostate Brachytherapy
|
Guthier, C.
|
|
|
158 |
S1 |
p. S118-S119
|
article
|
| 186 |
PP-0157 Long-term Outcomes of Prostate Cancer Patients treated with Low Dose Rate Brachytherapy
|
McMullan, T.
|
|
|
158 |
S1 |
p. S120-S122
|
article
|
| 187 |
PP-0161 mpMRI-guided dose escalation to DIL with US-planned HDR prostate brachytherapy: a phase II study
|
Ding, J.
|
|
|
158 |
S1 |
p. S124
|
article
|
| 188 |
PP-0162 MR-assisted whole salvage HDR prostate brachytherapy with intra-prostatic boost: a prospective study
|
Chung, H.
|
|
|
158 |
S1 |
p. S124-S125
|
article
|
| 189 |
PP-0122 MRI based tumour radiomics in carcinoma cervix: a potential predictor of response to chemoradiation
|
Nayak, P.
|
|
|
158 |
S1 |
p. S91
|
article
|
| 190 |
PP-0152 Proof of principle measurements for an intensity modulated brachytherapy tandem
|
Morcos, M.
|
|
|
158 |
S1 |
p. S116-S117
|
article
|
| 191 |
PP-0160 Prostatitis after HDR brachytherapy monotherapy
|
Jolicoeur, M.
|
|
|
158 |
S1 |
p. S123-S124
|
article
|
| 192 |
PP-0146 Quality assurance of curved catheter paths in interstitial brachytherapy using a constructed phantom
|
Abu-Hossin, N.
|
|
|
158 |
S1 |
p. S110-S111
|
article
|
| 193 |
PP-0158 Registration accuracy of an integrated MR -TRUS navigation system for prostate HDR brachytherapy
|
Kadoury, S.
|
|
|
158 |
S1 |
p. S122-S123
|
article
|
| 194 |
PP-0142 Vaginal dose de-escalation in cervix brachytherapy
|
Aldred, G.
|
|
|
158 |
S1 |
p. S107
|
article
|
| 195 |
PP-0163 Very long-term biochemical and dosimetric outcomes of LDR boost in intermediate-risk prostate cancer
|
Goñi Ramirez, A.
|
|
|
158 |
S1 |
p. S125-S126
|
article
|
| 196 |
PP-0147 Volumetric dosimetry for eye plaque brachytherapy using 3D treatment planning software
|
Rezaee, M.
|
|
|
158 |
S1 |
p. S111-S112
|
article
|
| 197 |
PP-0167 what about post-operative high-dose-rate brachytherapy in the management of keloids? 5-year outcomes
|
Noubbigh, G.E.F.
|
|
|
158 |
S1 |
p. S129-S130
|
article
|
| 198 |
SP-0002
|
Schmid, M.
|
|
|
158 |
S1 |
p. S1
|
article
|
| 199 |
SP-0073 Advocating global availability of cervical cancer brachytherapy
|
Chopra, S.
|
|
|
158 |
S1 |
p. S56
|
article
|
| 200 |
SP-0078 Against the motion
|
Kaidar-Person, O.
|
|
|
158 |
S1 |
p. S57
|
article
|
| 201 |
SP-0030 Against the motion: Data, data, data
|
Spratt, D.
|
|
|
158 |
S1 |
p. S20
|
article
|
| 202 |
SP-0080 Against the motion rebuttal
|
Meattini, I.
|
|
|
158 |
S1 |
p. S57-S58
|
article
|
| 203 |
SP-0032 Against the motion rebuttal: Brachytherapy Boost for Prostate Cancer - A Diminishing Solution
|
Martin, J.
|
|
|
158 |
S1 |
p. S20-S21
|
article
|
| 204 |
SP-0127 Automation for treatment planning and quality assurance (actual advancements)
|
Deufel, C.
|
|
|
158 |
S1 |
p. S93
|
article
|
| 205 |
SP-0093 Brachytherapy a useful tool for nasal and peri-nasal tumours
|
Johansson, B.
|
|
|
158 |
S1 |
p. S62
|
article
|
| 206 |
SP-0034 Brachytherapy Choice of the best approach for eye melanoma
|
Sagoo, M.S.
|
|
|
158 |
S1 |
p. S21
|
article
|
| 207 |
SP-0074 Brachytherapy Disparity and Challenges of Reimbursement in the United States
|
Orio, P.
|
|
|
158 |
S1 |
p. S56
|
article
|
| 208 |
SP-0137 Brachytherapy: Strategies to improve utilization in various sites and settings (ABS Viewpoint)
|
Yashar, C.
|
|
|
158 |
S1 |
p. S103
|
article
|
| 209 |
SP-0139 Brachytherapy: Strategies to improve utilization in various sites and settings (ALATRO viewpoint)
|
Del Castillo Pacora., R.
|
|
|
158 |
S1 |
p. S104-S105
|
article
|
| 210 |
SP-0138 Brachytherapy: Strategies to improve utilization in various sites and settings: (IBS Viewpoint)
|
Sharma, D.N.
|
|
|
158 |
S1 |
p. S104
|
article
|
| 211 |
SP-0036 Brachytherapy toxicity: diagnosis, therapies and preventive strategies
|
Blasi, M.A.
|
|
|
158 |
S1 |
p. S21-S22
|
article
|
| 212 |
SP-0009 Calibration at the clinical level for HDR and LDR brachytherapy sources
|
Rivard, M.
|
|
|
158 |
S1 |
p. S4-S5
|
article
|
| 213 |
SP-0123 Can Imaging technique affect treatment planning in brachytherapy of rectal and anal canal carcinomas?
|
Gerard, J.
|
|
|
158 |
S1 |
p. S91-S92
|
article
|
| 214 |
SP-0005 Cervical Cancer Brachytherapy at Washington University: 1920-2020
|
Grigsby, P.
|
|
|
158 |
S1 |
p. S3
|
article
|
| 215 |
SP-0010 Dosimetry beyond TG43 - Radiobiological models combined with model based and deep convolutional neural network algorithms
|
Enger, S.
|
|
|
158 |
S1 |
p. S5
|
article
|
| 216 |
SP-0003 EMBR ACE experience
|
Pötter, Richard
|
|
|
158 |
S1 |
p. S1-S2
|
article
|
| 217 |
SP-0077 For the motion
|
Hannoun-Levi, J.
|
|
|
158 |
S1 |
p. S57
|
article
|
| 218 |
SP-0031 For the motion rebuttal
|
Gomez Iturriaga, A.
|
|
|
158 |
S1 |
p. S20
|
article
|
| 219 |
SP-0079 For the motion rebuttal
|
Kuske, R.
|
|
|
158 |
S1 |
p. S57
|
article
|
| 220 |
SP-0124 Gallbladder: status of the art
|
Devlin, P.
|
|
|
158 |
S1 |
p. S92
|
article
|
| 221 |
SP-0098 GEC-ESTRO/ABS/CBG recommendations on target definition in vaginal recurrence
|
Kamrava, M.
|
|
|
158 |
S1 |
p. S66-S67
|
article
|
| 222 |
SP-0097 GEC-ESTRO/IBS/ABS recommendations for treatment planning
|
Beriwal, S.
|
|
|
158 |
S1 |
p. S65-S66
|
article
|
| 223 |
SP-0136 GEC-ESTRO viewpoint in strategies to increase brachytherapy utilization
|
Pieters, B.
|
|
|
158 |
S1 |
p. S102-S103
|
article
|
| 224 |
SP-0052 HDR prostate brachytherapy and fractionation; does it matter?
|
Millar, J.
|
|
|
158 |
S1 |
p. S40-S41
|
article
|
| 225 |
SP-0089 How to implement and execute an incident learning system
|
Fong de los Santos, L.
|
|
|
158 |
S1 |
p. S61
|
article
|
| 226 |
SP-0095 IBS/GEC-ESTRO recommendations for CT based treatment of cervical cancer
|
Mahantshetty, U.
|
|
|
158 |
S1 |
p. S63-S64
|
article
|
| 227 |
SP-0004 Image guided Brachytherapy and Outcomes of Cervical Cancer:: Indian Experience
|
Gurram, L.
|
|
|
158 |
S1 |
p. S2-S3
|
article
|
| 228 |
SP-0126 Image registration, Automated segmentation, and Dose Summation
|
De Brabandere, M.
|
|
|
158 |
S1 |
p. S92-S93
|
article
|
| 229 |
SP-0054 Increasing the degrees of freedom with applicators
|
Damato., A.
|
|
|
158 |
S1 |
p. S41
|
article
|
| 230 |
SP-0056 In vivo HDR brachytherapy source tracking with point dosimeters: current status and future directions
|
Poder, J.
|
|
|
158 |
S1 |
p. S42-S43
|
article
|
| 231 |
SP-0057 In vivo source tracking with imaging panels and fluoroscopy
|
Paiva Fonseca, G.
|
|
|
158 |
S1 |
p. S43-S44
|
article
|
| 232 |
SP-0096 JASTRO recommendations for CT based brachytherapy for cervical cancer
|
Ohno, T.
|
|
|
158 |
S1 |
p. S65
|
article
|
| 233 |
SP-0053 LDR prostate brachytherapy is safe and effective for all localized prostate cancer risk groups
|
Davis, B.
|
|
|
158 |
S1 |
p. S41
|
article
|
| 234 |
SP-0076 Motivating the next generation of brachytherapy trainees
|
Sturdza, A.
|
|
|
158 |
S1 |
p. S57
|
article
|
| 235 |
SP-0007 Nuclides and dose delivery devices – An overview and Comparison
|
Perez Calatayud, J.
|
|
|
158 |
S1 |
p. S4
|
article
|
| 236 |
SP-0125 Oesophagus: An orphan topic?
|
Rovirosa, A.
|
|
|
158 |
S1 |
p. S92
|
article
|
| 237 |
SP-0085 Ongoing clinical trials and future trends of APBI
|
Wazer, D.
|
|
|
158 |
S1 |
p. S59-S60
|
article
|
| 238 |
SP-0082 Results of brachytherapy trials
|
Strnad, V.
|
|
|
158 |
S1 |
p. S58
|
article
|
| 239 |
SP-0083 Results of external beam radiotherapy trials
|
Bhattacharya, I.
|
|
|
158 |
S1 |
p. S59
|
article
|
| 240 |
SP-0084 Results of IORT (Intra-Operative Radiation Therapy) trials
|
Orecchia, R.
|
|
|
158 |
S1 |
p. S59
|
article
|
| 241 |
SP-0050 Single dose HDR brachytherapy is safe for low-risk prostate cancer
|
Hoskin, P.
|
|
|
158 |
S1 |
p. S39
|
article
|
| 242 |
SP-0051 Single dose HDR prostate brachytherapy and residual disease
|
Morton, G.
|
|
|
158 |
S1 |
p. S39-S40
|
article
|
| 243 |
SP-0070 The next generation brachytherapists
|
Petereit, D.
|
|
|
158 |
S1 |
p. S55-S56
|
article
|
| 244 |
SP-0035 The role of interstitial radiotherapy in orbital tumors or extrascleral uveal melanoma
|
Kovács, G.
|
|
|
158 |
S1 |
p. S21
|
article
|
| 245 |
SP-0128 The role of physics, dosimetry, and physicians in an era of automation: how will our practice change?
|
Cunha, A.
|
|
|
158 |
S1 |
p. S93
|
article
|
| 246 |
SP-0029 This house believes: Combination therapy for intermediate and high-risk pCa represents the best standard of care
|
Keyes, M.
|
|
|
158 |
S1 |
p. S19-S20
|
article
|
| 247 |
SP-0091 This house believes that radiotherapy/brachytherapy should be considered for lip high risk non-melanoma skin cancer
|
Budrukkar, A.
|
|
|
158 |
S1 |
p. S61
|
article
|
| 248 |
SP-0090 This house believes that surgery should be considered for lip high risk non-melanoma skin cancer
|
Newlands, C.
|
|
|
158 |
S1 |
p. S61
|
article
|
| 249 |
SP-0092 This house believes that surgery should be considered for nose high risk non-melanoma skin cancer\r
|
Bussu, F.
|
|
|
158 |
S1 |
p. S61-S62
|
article
|
| 250 |
SP-0008 Traceability of LDR and HDR source calibration.
|
Schneider, T.
|
|
|
158 |
S1 |
p. S4
|
article
|
| 251 |
SP-0006 Transition from 2D to MRI-based adaptive brachytherapy, Chulalongkorn University experience.
|
Amornwichet, N.
|
|
|
158 |
S1 |
p. S3-S4
|
article
|
| 252 |
SP-0055 Update by the ESTRO task group on in vivo dosimetry in brachytherapy
|
Johansen, J.
|
|
|
158 |
S1 |
p. S41-S42
|
article
|
| 253 |
SP-0049 Using health economics to make the case for brachytherapy – HALYS, QALYS and DALYS
|
Milosevic, M.
|
|
|
158 |
S1 |
p. S38-S39
|
article
|
| 254 |
SP-0075 Utilizing time activity based costing to determine the real costs of brachytherapy
|
Kamrava, M.
|
|
|
158 |
S1 |
p. S56-S57
|
article
|
| 255 |
SP-0129 What is this thing called AI and how can it help brachytherapy?
|
Bosman, P.
|
|
|
158 |
S1 |
p. S93-S94
|
article
|
| 256 |
SP-0088 Why Brachytherapy?
|
Martinez-Monge, R.
|
|
|
158 |
S1 |
p. S60-S61
|
article
|
| 257 |
SP-0087 Why EBRT?
|
Bonomo, P.
|
|
|
158 |
S1 |
p. S60
|
article
|
| 258 |
SP-0086 Why surgery?
|
Bruchhage, K.
|
|
|
158 |
S1 |
p. S60
|
article
|
| 259 |
SP-0072 Will Brachytherapy Survive the Radical Changes Facing Medicine?
|
Martinez, A.
|
|
|
158 |
S1 |
p. S56
|
article
|
| 260 |
Title Page
|
|
|
|
158 |
S1 |
p. i
|
article
|
Journal description